Pontifax Management 4 G.P., 10% Owner: LB Pharmaceuticals LBRX Buy · Filed 25/09/16

Trade details

Type: Insider buy
Amount: $15,000,000
Shares · price: 1,000,000 sh · $15.00 a share
Held after: 1,411,681 sh
Stock: LB Pharmaceuticals LBRX
Person: Pontifax Management 4 G.P.10% Owner
Trade date: 25/09/12
Filed: 25/09/16
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 10 insiders
Holding change: +242.9%

LB Pharmaceuticals trades, last 26 weeks

What else happened in LB Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/13~25/10/12

Pontifax Management 4 G.P.'s recent trades

Pontifax Management 4 G.P.10% Owner
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$40.6M
2,284,612 sh
$40.6M
Filed 25/10/17
Traded 25/10/15
Pontifax Management 4 G.P.10% Owner
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$21.8M
1,226,412 sh
$21.8M
Filed 25/10/17
Traded 25/10/15
Pontifax Management 4 G.P.10% Owner
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$19.9M
1,121,045 sh
$19.9M
Filed 25/10/17
Traded 25/10/15
Pontifax Management 4 G.P.10% Owner
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$2.8M
155,262 sh
$2.8M
Filed 25/10/17
Traded 25/10/15